Determinants of seropositivity among HPV-16/18 DNA positive young women.
about
Cross-sectional study of HPV-16 infection in a population-based subsample of Hispanic adults.A study of cervical intraepithelial neoplasia in pregnancy.Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study.Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with menHuman papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational studyOncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer.The role of sexual behavior in head and neck cancer: implications for prevention and therapy.Next Generation Cancer Protection: The Bivalent HPV Vaccine for FemalesHPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.A review of methods for detect human Papillomavirus infectionDeterminants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women.Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.Review: current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme.Smoking and subsequent human papillomavirus infection: a mediation analysis.Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
P2860
Q30571320-A380290F-BF37-494F-8FF5-0F628E16ED8CQ33770159-70A984C0-7DF9-4262-A43E-C95C78FCDA6CQ33953881-62A2C052-7C25-4094-84A0-D0B4921CA67DQ34546550-AB3451F2-CBDA-4713-BE5F-E807D9879C59Q34587057-E233814D-F02E-4AC5-99EC-BE5218BCEDD1Q34873067-E26B73DC-6FFE-461D-8C65-F7C114D7F5A5Q34987731-053E6126-CF22-49BD-8965-46AB2F7C76B3Q35054754-BAA6CB3D-0278-4439-8EE4-C9B689C16C1BQ35272050-094D7ABB-B7B4-47B4-8845-AA3C67FB8A4AQ35550810-4E3F93FA-D76C-4BB0-868C-C25CCA52B953Q35750840-C0D38691-EBEB-4592-AE2D-48D9092431E9Q36427451-3CFCD573-A904-4B81-B84A-45E54F2FE03FQ36565494-2E1C3BA1-FABE-4741-AAF9-AD9034A135FBQ36921606-389C525A-6685-4C8D-ACEE-084BD3729069Q38110696-B50E92CF-C9E9-4540-A544-16597EEB503BQ50137874-50E8FAC2-2202-45B3-BBA0-487DA230BC54Q53430838-5410CB30-B538-4842-83E9-CB2B4DC2CE12
P2860
Determinants of seropositivity among HPV-16/18 DNA positive young women.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Determinants of seropositivity among HPV-16/18 DNA positive young women.
@ast
Determinants of seropositivity among HPV-16/18 DNA positive young women.
@en
type
label
Determinants of seropositivity among HPV-16/18 DNA positive young women.
@ast
Determinants of seropositivity among HPV-16/18 DNA positive young women.
@en
prefLabel
Determinants of seropositivity among HPV-16/18 DNA positive young women.
@ast
Determinants of seropositivity among HPV-16/18 DNA positive young women.
@en
P2093
P2860
P50
P356
P1476
Determinants of seropositivity among HPV-16/18 DNA positive young women.
@en
P2093
Carolina Porras
Catherine Bougelet
Christina Bennett
Costa Rica HPV Vaccine Trial (CVT) Group
Diane Solomon
Mark E Sherman
Martha Hutchinson
Paula González
Rolando Herrero
Sarah Coseo
P2860
P2888
P356
10.1186/1471-2334-10-238
P50
P577
2010-08-11T00:00:00Z
P5875
P6179
1029927020